Results 31 to 40 of about 96,770 (285)
Kidney & Blood Pressure Research, 2018 Background/Aims: Whether angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB) could benefit patients with diabetes and albuminuria remains controversial.
Kanran Wang +7 more
doaj +1 more source
Ace inhibitors and cardiac remodeling in congestive heart failure
, 2021 The thesis explains in detail the pathophysiology of heart failure and the role of Ace inhibitors in slowing the progression of heart failure by directly and indirectly slowing cardiac myocytes remodeling and ventricular hypertrophyáltalános ...
Abu Ghazaleh, Mohammad
core
ACE Inhibitors and Chronotherapy
Clinical and Experimental Hypertension, 2005 Chronotherapy can improve the effectiveness and reduce the adverse reactions of drugs and actually is used for several conditions including cardiovascular diseases. Although angiotensin converting enzyme (ACE) inhibitors are available for the therapy of patients with hypertension and/or heart failure, these agents have some characteristic adverse ...
Masami, Ohmori, Akio, Fujimura
openaire +2 more sources
Circulation, 1998 To the Editor: In a recent issue of Circulation , Brown and Vaughan1 reviewed ACE inhibitors. They stated that captopril and lisinopril are active drugs and listed 7 other ACE inhibitors approved in the United States that are inactive prodrugs until metabolized in the liver.
openaire +2 more sources
International Journal of Pharmacy & Integrated Health SciencesBackground: There is good evidence that angiotensin-converting enzyme (ACE) inhibitors are beneficial after myocardial infarction (MI). However, it is not known how widely this evidence is used in practice or whether all eligible patients receive this ...
Fiaz Alam +6 more
doaj +1 more source
FEBS Open Bio, 2015 Angiotensin converting enzyme (ACE) is a zinc‐dependent dipeptidyl carboxypeptidase with an essential role in blood pressure homeostasis in mammals.
Charlotte Harrison, K. Ravi Acharya
doaj +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction This study investigated the safety and efficacy of single‐needle Rheocarna therapy for chronic limb‐threatening ischemia (CLTI) with wounds. Methods Six patients with CLTI involving ulcers unresponsive to revascularization underwent single‐needle Rheocarna treatment.
Yasutaka Yamauchi +9 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
FEBS Letters, EarlyView.Enteropathogenic E. coli (EPEC) infects the human intestinal epithelium, resulting in severe illness and diarrhoea. In this study, we compared the infection of cancer‐derived cell lines with human organoid‐derived models of the small intestine. We observed a delayed in attachment, inflammation and cell death on primary cells, indicating that host ...
Mastura Neyazi +5 more
wiley +1 more source
Impact of angiotensin converting enzyme inhibition on post- coronary artery bypass interleukin 6 release [PDF]
, 2002 Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti- inflammatory action.
Humphries, S.E. +5 more
core